Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling. [electronic resource]
Producer: 20201207Description: 61 p. digitalISSN:- 1742-2094
- Alzheimer Disease -- drug therapy
- Amyloid beta-Protein Precursor -- genetics
- Animals
- Animals, Newborn
- Cells, Cultured
- Female
- Humans
- MAP Kinase Signaling System -- drug effects
- Male
- Maze Learning -- drug effects
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Nesting Behavior -- drug effects
- Presenilin-1 -- genetics
- Sesquiterpenes -- pharmacology
- Social Interaction
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.